Self-injected Depot–Medroxyprogesterone Acetate Subcutaneous (DMPA-SC) Uptake in Nigeria: A Paradigm Shift

Download Article

DOI: 10.21522/TIJAR.2014.08.03.Art007

Authors : Kehinde Osinowo, Femi Rufus Tinuola, Oluwaseun Ojomo, Segun Ibitoye, Philip Oluwayemi


Self-injection of DMPA-SC method is one of the Government of Nigeria’s (GON) national family planning goals to address the unmet need for contraception. Some studies on DMPA-SC/SI have demonstrated its feasibility to improve modern contraceptive uptake. However, there is a gap in the predictors of method uptake and continuation across self-injecting and provider-administered in Nigeria. This study explored the uptake of self-injection DMPA-SC contraceptives among women in two geopolitical zones of Nigeria. The study employed 20 focused group discussions (FGDs) and 40 In-depth interviews (IDIs). Self-structured pretested questionnaire to elicit information from 844 women registered for Family Planning in selected health facilities. Descriptive statistics were calculated and multivariate logistic regression was used to model determinants of DMPA-SC/SI family planning uptake. Six months of Secondary Data from the Health Management Information system (HMIS) was used to triangulate the trends in uptake. About 97.6% reported ever heard DMPA-SC/SI family planning method; 78.4% reported its uptake; while 88.5% reported ever heard of self-injection as an option of family planning method. Data for each State showed a remarkable increase in uptake of DMPA-SC/SI. The motivations to use DMPA-SC/Self Injection were ease of accessibility, convenience, and self-administer/care. Factors that encourage the uptake of DMPA-SC/SI were; health benefits, the prevailing economic situation and its effectiveness. Findings from the study showed that interventions that deploy health education, awareness, social mobilization, advocacy, policy implementation, and public sensitization, making contraceptive services available for free, will increase the uptake of DMPA-SC/SI in the study areas.


[1] United Nations, Department of Economic and Social Affairs, Population Division. Contraceptive Use by Method 2019: Data Booklet. UN. Epub ahead of print December 10, 2019. DOI: 10.18356/1bd58a10-en.

[2] Kantorová V, New JR, Biddlecom A, et al. Setting Ambitious yet Achievable Targets Using Probabilistic Projections: Meeting Demand for Family Planning. Stud Fam Plann 2017; 48: 223–233.

[3] Sedgh G, Ashford LS, Hussain R. Unmet Need for Contraception in Developing Countries: Examining Women’s Reasons for Not Using a Method. N Y Guttmacher Inst 2016; 93.

[4] Thapa P, Pokharel N, Shrestha M. Knowledge, Attitude and Practices of Contraception among the Married Women of Reproductive Age Group in Selected Wards of Dharan Sub-Metropolitan City. J Contracept Stud 2018; 03: 18.

[5] National Population Commission (NPC) [Nigeria] and ICF. 2019. Nigeria Demographic and Health Survey 2018, (2019, accessed October 24, 2020).

[6] Okunade K, Daramola E, Ajepe A, et al. A 3-year review of the pattern of contraceptive use among women attending the family planning clinic of a University Teaching Hospital in Lagos, Nigeria. Afr J Med Health Sci 2016; 15: 69.

[7] Singhal S. Impact of Injectable Progestogen Contraception in Early Puerperium on Lactation and Infant Health. J Clin Diagn Res. Epub ahead of print 2014. DOI: 10.7860/JCDR/2014/7775.4110.

[8] Beson P, Appiah R, Adomah-Afari A. Modern contraceptive use among reproductive-aged women in Ghana: prevalence, predictors, and policy implications. BMC Women’s Health 2018; 18: 157.

[9] Starbird E, Norton M, Marcus R. Investing in Family Planning: Key to Achieving the Sustainable Development Goals. Glob Health Sci Pract 2016; 4: 191–210.

[10] Schrumpf LA, Stephens MJ, Nsarko NE, et al. Side effect concerns and their impact on Women’s uptake of modern family planning methods in rural Ghana: a mixed-methods study. BMC Women’s Health 2020; 20: 57.

[11] Darroch JE. Adding It Up: Investing in Contraception and Maternal and Newborn Health, 2017—Estimation Methodology. N Y Guttmacher Inst 2018; 97.

[12] PATH. DMPA-SC self-injection supports women to use injectable contraception longer. F Poptionspathorg ǀ Wwwpathorgdmpa-Sc 2018; 2.

[13] Cover J, Namagembe A, Tumusiime J, et al. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda. Contraception 2018; 98: 383–388.

[14] Kohn JE, Simons HR, Della Badia L, et al. Increased 1-year Continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood. Contraception 2018; 97: 198–204.

[15] Liu J, Shen J, Diamond-Smith N. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects. Contraception 2018; 98: 430–437.

[16] Ahuru RR. The influence of women empowerment on maternal and childcare use in Nigeria. Int J Healthc Manag 2019; 1–10.

[17] Cochran WG. Professor of Statistics, Emeritus Harvard University. 10.

[18] Yaya S, Uthman OA, Ekholuenetale M, et al. Women empowerment as an enabling factor of contraceptive use in sub-Saharan Africa: a multilevel analysis of cross-sectional surveys of 32 countries. Reprod Health 2018; 15: 214.

[19] Adebowale SA, Ajiboye BV, Arulogun O. Patterns and Correlates of Condom Use among Unmarried Male Youths in Nigeria: NDHS 2008. Afr J Reprod Health 2017; 17: 149–159.

[20] Ahuru R, Nzoputam C. Barriers to use of modern contraceptive among reproductive-age women in rural communities in Delta State, Southern Nigeria. 2020; 9: 15–32.

[21] Aliyu AA, Dahiru T. Reproductive Health and Family Planning Services in Africa: Looking beyond Individual and Household Factors. In: Amarin Z, Abduljabbar H (eds) Family Planning and Reproductive Health. IntechOpen. Epub ahead of print December 2, 2020. DOI: 10.5772/intechopen.92138.

[22] Burke HM, Chen M, Buluzi M, et al. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial. Lancet Glob Health 2018; 6: e568–e578.

[23] Kanwal N, Muttappallymyalil J, Al-Sharbatti S, et al. Contraceptive Utilisation Among Mothers of Reproductive Age in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J 2017; 17: e50–e58.

[24] Olugbenga-Bello AI, Adebimpe WO, Akande RO, et al. Health risk behaviors and sexual initiation among in-school adolescents in rural communities in southwestern Nigeria. Int J Adolesc Med Health 2014; 26: 503–510.

[25] Solanke BL. Factors influencing contraceptive use and non-use among women of advanced reproductive age in Nigeria. J Health Popul Nutr 2017; 36: 1.

[26] Abasiattai A, Udoma E, Ukeme E. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo. Ann Afr Med 2010; 9: 81.

[27] Mairiga AG, Kyari O, Audu B, et al. Socio-clinical characteristics of modern contraceptives users at the University of Maiduguri Teaching Hospital. Niger J Clin Pract 2007; 10: 152–155.

[28] Ochako R, Mbondo M, Aloo S, et al. Barriers to modern contraceptive methods uptake among young women in Kenya: a qualitative study. BMC Public Health 2015; 15: 118.

[29] Do M, Kurimoto N. Women’s Empowerment and Choice of Contraceptive Methods in Selected African Countries. Int Perspect Sex Reprod Health 2012; 38: 023–033.

[30] Yaya S, Uthman OA, Ekholuenetale M, et al. Effects of birth spacing on adverse childhood health
outcomes: evidence from 34 countries in sub-Saharan Africa. J Matern Fetal Neonatal Med 2020; 33: 3501–3508.

[31] Sedgh G, Hussain R. Reasons for Contraceptive Nonuse among Women Having Unmet Need for Contraception in Developing Countries. Stud Fam Plann 2014; 45: 151–169.

[32] Chimah U, Lawoyin T, Ilika A, et al. Contraceptive knowledge and practice among senior secondary schools’ students in military barracks in Nigeria. Niger J Clin Pract 2016; 19: 182.

[33] Gage AJ. Sexual Activity and Contraceptive Use: The Components of the Decisionmaking Process. Stud Fam Plann 1998; 29: 154.